Roadblocks and Potential Solutions in Anticancer Drug Development
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
Author:
Silvia Licciulli, PhD
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
The new year brings a new chapter in the holy book of cancer biology with the publication in the...
The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal...
Triple-negative breast cancer (TNBC) is aggressive, with high risk of metastasis and recurrence, and is challenging to treat due to a lack of effective targeted therapies. However, a higher...
Cancer is a very complex disease. Cancer cells often have the ability to rewire some of their functions to survive in harsh...
Liver cancer is the second most common cause of cancer-related deaths worldwide. In 2021, it is estimated that more...